Page last updated: 2024-11-05

triethylene glycol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Triethylene glycol (TEG) is a colorless, viscous liquid with a faint odor. It is a synthetic compound with the chemical formula C6H14O4. TEG is produced through the reaction of ethylene oxide with water in the presence of a catalyst. It is primarily used as a desiccant (drying agent) in natural gas processing and other industrial applications. TEG is also used as a solvent, plasticizer, and component in hydraulic fluids. It is studied extensively due to its high hygroscopicity, which makes it effective for removing water vapor from gas streams. Research focuses on optimizing its performance, improving its efficiency, and exploring its potential applications in various industries. TEG is considered a relatively safe compound, but its handling requires precautions due to its potential for skin and eye irritation. It is also considered a potential environmental hazard due to its bioaccumulation in aquatic environments.'

triethylene glycol : A poly(ethylene glycol) that is octane-1,8-diol in which the carbon atoms at positions 3 and 6 have been replaced by oxygen atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8172
CHEMBL ID1235259
CHEBI ID44926
SCHEMBL ID14929
MeSH IDM0092649

Synonyms (138)

Synonym
CHEMBL1235259
nsc-60758
glycol bis(hydroxyethyl) ether
ethanol,2'-[1,2-ethanediylbis(oxy)]bis-
2,2'-ethylenedioxydiethanol
1,2-bis(2-hydroxyethoxy)ethane
3,8-diol
teg ,
trigen
nsc60758
di-.beta.-hydroxyethoxyethane
2,2'-ethylenedioxyethanol
ethylene glycol dihydroxydiethyl ether
ethanol,2'-(ethylenedioxy)di-
wln: q2o2o2q
triglycol
triethylene glycol
tri-ethylene glycol
2-[2-(2-hydroxyethoxy)ethoxy]ethanol
3,6-dioxa-1,8-octanediol
112-27-6
2,2'-[ethane-1,2-diylbis(oxy)]diethanol
inchi=1/c6h14o4/c7-1-3-9-5-6-10-4-2-8/h7-8h,1-6h
ethanol, 2,2'-[1,2-ethanediylbis(oxy)]bis-
ethanol, 2,2'-(ethylenedioxy)di-
triethyleneglycol
einecs 203-953-2
caswell no. 888
hsdb 898
ai3-01453
nsc 60758
epa pesticide chemical code 083501
2,2'-(ethylenedioxy)diethanol
brn 0969357
2,2'-(1,2-ethanediylbis(oxy))bisethanol
ethylene glycol-bis-(2-hydroxyethyl ether)
triethylenglykol [czech]
bis(2-hydroxyethoxyethane)
ethanol, 2,2'-(1,2-ethanediylbis(oxy))bis-
2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethanol
triethylene glycol, reagentplus(r), 99%
DB02327
NCGC00163798-03
3,6-dioxaoctane-1,8-diol
di-beta-hydroxyethoxyethane
NCGC00163798-02
2,2'-ethylenedioxybis(ethanol)
NCGC00163798-01
triethylenglykol
CHEBI:44926 ,
triethylene glycol, bioultra, anhydrous, >=99.0% (gc)
FT-0652416
FT-0659862
T0428
AKOS000120013
NCGC00163798-04
NCGC00163798-05
103734-98-1
122784-99-0
tox21_300306
NCGC00254097-01
tox21_202440
dtxcid601393
tox21_112073
NCGC00259989-01
cas-112-27-6
dtxsid4021393 ,
145112-98-7
trigol
STL282716
ccris 8926
3p5su53360 ,
4-01-00-02400 (beilstein handbook reference)
unii-3p5su53360
ec 203-953-2
137800-98-7
2,2'-(ethane-1,2-diylbis(oxy))diethanol
triethylene glycol [inci]
peg-3
triethylene glycol [mi]
macrogol 150
triethylene glycol [who-dd]
triethylene glycol [hsdb]
triethylene glycol [usp-rs]
triethylene glcol
BP-21036
SCHEMBL14929
triethylenglycol
triethylene-glycol
mfcd01779599
STR02345
2-[2-(2-hydroxyethoxy)ethoxy]ethan-1-ol
trigenos
2-[2-(2-hydroxyethoxy)ethoxy]ethanol #
J-506706
mfcd01779596
mfcd01779609
mfcd01779611
mfcd01779614
mfcd00081839
mfcd01779603
mfcd01779605
mfcd01779616
mfcd01779612
mfcd01779601
mfcd00002880
mfcd01779615
sr-01000944720
SR-01000944720-1
triethylene glycol, united states pharmacopeia (usp) reference standard
triethylene glycol, saj first grade, >=96.0%
triethylene glycol, puriss.
triethylene glycol, vetec(tm) reagent grade, 98%
2,2'-(ethane-1,2-diylbis(oxy))bis(ethan-1-ol)
F0001-0256
triethyleneglycol,
CS-W018156
119438-10-7
Q420630
AMY375
HY-W017440
NCGC00163798-06
oh-peg3-oh
EN300-19916
usepa/opp pesticide code: 083501
triethylene glycol dimaleate
ethanol, 2,2'-(1,2-ethanediylbis (oxy))bis-
triethylene glycol (usp-rs)
1,2-di(beta-hydroxyethoxy)ethane
1,8-dihydroxy-3,6-dioxaoctane
ethylene glycol-bis(2-hydroxyethyl)ether
ethylene glycol-bis-(2-hydroxyethyl)ether
2-(2-(2-hydroxy-ethoxy)-ethoxy)-ethanol
2,2'-(1,2-ethanediyl bis (oxy))-bisethanol
teg (glycol)
2-(2-(2-hydroxyethoxy)ethoxy)ethanol
F71165
Z104476078

Research Excerpts

Overview

Triethylene glycol (TEG) is a liquid industrial chemical with a potential for human exposure. TEG is a specific three-unit chain, whereas PEG-4 is a polymer with an average of four units.

ExcerptReferenceRelevance
"Triethylene glycol (TEG) is a liquid industrial chemical with a potential for human exposure. "( Developmental toxicity study with triethylene glycol given by gavage to CD rats and CD-1 mice.
Ballantyne, B; Snellings, WM,
)
1.85
"Triethylene Glycol is a specific three-unit chain, whereas PEG-4 is a polymer with an average of four units, but may contain polymers ranging from two to eight ethylene oxide units."( Final report on the safety assessment of Triethylene Glycol and PEG-4.
, 2006
)
1.32

Effects

ExcerptReferenceRelevance
"Triethylene glycol metabolism has previously been shown to be inhibited by fomepizole (4-methyl pyrazole) administration."( Triethylene glycol poisoning treated with intravenous ethanol infusion.
Dowsett, RP; Graudins, A; Vassiliadis, J, 1999
)
2.47

Toxicity

ExcerptReferenceRelevance
"The potential for adverse effects from exposure to respirable aerosols of triethylene glycol (TEG: CAS Number 112-27-6) was investigated by a peripheral chemosensory irritation study, and by acute and repeated exposure toxicity studies."( Respiratory peripheral chemosensory irritation, acute and repeated exposure toxicity studies with aerosols of triethylene glycol.
Ballantyne, B; Norris, JC; Snellings, WM,
)
0.57
" With oral LD50 values in rodents from 15 to 22 g/kg, this compound has little acute toxicity."( Final report on the safety assessment of Triethylene Glycol and PEG-4.
, 2006
)
0.6
"The epoxy compound 2,3-EMA induced comparable toxic effects as the raw comonomer TEGDMA."( Cytotoxicity of the dental composite component TEGDMA and selected metabolic by-products in human pulmonary cells.
Emmler, J; Hickel, R; Kehe, K; Kreppel, H; Reichl, FX; Seiss, M, 2008
)
0.35
" Prefibrillar species were more toxic than mature fibrils."( Dendrimers reduce toxicity of Aβ 1-28 peptide during aggregation and accelerate fibril formation.
Correa, J; Fernandez-Megia, E; Fernandez-Villamarin, M; Ionov, M; Klajnert, B; Riguera, R; Sousa-Herves, A; Wasiak, T, 2012
)
0.38
" Intratracheal instillation of BAC (400 μg/kg) in rats was toxic to the pulmonary tissues while that of TEG (up to 1000 μg/kg) did not show any harmful effect."( Evaluation of pulmonary toxicity of benzalkonium chloride and triethylene glycol mixtures using in vitro and in vivo systems.
Kim, E; Kim, HM; Kim, P; Kwon, D; Kwon, JT; Lee, DH; Lim, YM; Shim, I; Yoon, BI, 2019
)
0.75

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Body weights were reduced during the dosing period with both males and females of the high dosage."( Subchronic peroral toxicity of triethylene glycol in the Fischer 344 rat.
Ballantyne, B; Van Miller, JP, 2001
)
0.6
" Continuous subchronic peroral dosing of TEG in the diet of rats did not produce any systemic cumulative or long-term toxicity."( Triethylene glycol HO(CH2CH2O)3H.
Ballantyne, B; Snellings, WM,
)
1.57
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plasticiserAny compound that is used as an additive to increase the plasticity or fluidity of a substance, particularly but not exclusively to synthetic polymers.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
poly(ethylene glycol)A polymer composed of repeating ethyleneoxy units.
diolA compound that contains two hydroxy groups, generally assumed to be, but not necessarily, alcoholic. Aliphatic diols are also called glycols.
primary alcoholA primary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency14.10770.000221.22318,912.5098AID588515
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency44.91060.013326.981070.7614AID1346978
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency9.52050.000214.376460.0339AID720691
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency28.33670.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency41.76560.000817.505159.3239AID1159527; AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency71.43540.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency54.94100.000229.305416,493.5996AID743069
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency44.66840.001019.414170.9645AID588536
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency35.57670.023723.228263.5986AID588543; AID743223
caspase-3Homo sapiens (human)Potency44.91060.013326.981070.7614AID1346978
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency26.33660.000323.4451159.6830AID743065; AID743066
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency57.80670.000627.21521,122.0200AID651741; AID720636
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (165)

TimeframeStudies, This Drug (%)All Drugs %
pre-199041 (24.85)18.7374
1990's13 (7.88)18.2507
2000's32 (19.39)29.6817
2010's63 (38.18)24.3611
2020's16 (9.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 66.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index66.96 (24.57)
Research Supply Index5.18 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index113.21 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (66.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (3.39%)6.00%
Case Studies3 (1.69%)4.05%
Observational0 (0.00%)0.25%
Other168 (94.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]